, Department of Immunology and Allergology, Faculty of Medicine and Faculty Hospital in Pilsen, Nippon Medical School, vol.182

C. Dé-partement-de-pé-diatrie and . De-grenoble, Osijek, Croatia; 191 Karl Landsteiner Institute for Clinical and Experimental Pneumology, Hietzing Hospital, Clinic of Allergy & Asthma, Medical University Sofia, 0193.

, Academic Centre of Primary Care, Maison des Professions Libé rales, vol.198, 0200.

, Sã o Paulo, Brazil; 217 Kyrgyzstan National Centre of Cardiology and Internal medicine, 214 Sociedad Paraguaya de Alergia Asma e Inmunolog?a, vol.207

, Pneumology and Allergy Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, vol.224

, Sorbonne Université s, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidé miologie et de Santé Publique, Equipe EPAR, vol.263

, Department of Otorhinolaryngology, Head and Neck Surgery, Serbian Association for Asthma and COPD, vol.267

J. Bousquet, H. J. Schunemann, J. Fonseca, B. Samolinski, C. Bachert et al.,

M. Bewick, T. Bieber, C. Bindslev-jensen, L. Bjermer, H. Blain et al.,

F. Portejoie, D. Postma, P. Potter, D. Price, K. F. Rabe et al.,

R. Valenta, A. L. Valero, M. Van-hage, O. Vandenplas, G. Vezzani et al., The use of Interferon Lambda for the treatment and prevention of virally-induced exacerbation in asthma and chronic pulmonary obstructive disease. UK patent application No. 0518425, Virus Therapy for Respiratory Diseases (IFNb therapy) Hong Kong Patent Number 1097181, vol.70, p.31, 2002.

, Anti-Virus Therapy for Respiratory Diseases (IFNb therapy)

P. A. Wark, S. L. Johnston, S. T. Holgate, D. Davies, J. Almond et al., Allergopharma (Germany) and Boehringer Ingelheim (Germany). LK is Board Member of the ENT Section of the European Academy of Allergy and Clinical Immunology (EAACI), Vice-President of the German Academy of Allergology and Clinical Immunology, Vice-President German Union of Allergologists, Member of the Board of Directors of the German Society for Otorhinolaryngology HNS. He is co-editor and author of different chapters of the textbook, Interferon-beta for Anti-Virus Therapy for Respiratory Diseases. New Hong Kong -Divisional Patent Application No. 11100187.0, 10, vol.4807526, 2011.

, Gerard Koppelman: grants outside this work from Dutch Lung Foundation, Ubbo Emmius Foundation and Stichting Astma Bestrijding

P. Kuna, ;. Pfizer, . Mit, M. Glenmark, . Msd et al., personal fees from GSK, personal fees from HAL, personal fees from Meda, personal fees from MSD, personal fees from Novartis, personal fees from Pfizer, personal fees from Polfarmex, personal fees from Polpharma, personal fees from Stallergen, personal fees from Teva, personal fees from Lekam, outside the submitted work; D esir ee Larenas: Speaker para: Astrazeneca, reports personal fees from Adamed, personal fees from Allergopharma, personal fees from Almirall, personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, personal fees from Celon Pharma, personal fees from Chiesi, personal fees from FAES

A. Magnan, ;. Novartis, M. , A. -. Zeneca, A. Teva et al., enes; P Manning: Personal Benefits <$10 000: A. Menarrini, Shares: none, Non-Personal Interests/benefits >$10 000: none; Marcus Maurer: Grant/Research, Investigator: GSK Novartis Astra Zeneca Roche SANOFI Amgen Boehringer

, Abbott Laboratories; FAES; UCB

. Moxie, Consultant/Advisory Boards: Novartis Genentech; Uriach

A. Laboratories, ;. Faes;-msd;-almirall, ;. Ucb;-moxie, ;. Sanofi;-ralf-mosges, ;. Alk-abello et al., MSD, grants and personal fees from Arthrocare, Bencard, Stallerg enes, BiotechTools, Lofarma, grants from Ursapharm, Bitop, HAL, AIPreven, Optima, non-financial support from Greer, Roxall, personal fees and non-financial support from UCB, non-financial support from Atmos, outside the submitted work; member of the guidelines task force of the German Academy of Otorhinolaryngology, chairman of the International Standardisation Committee of the European Rhinologic Society (ERS) and chairman of the ENT-Section of the, European Academy of Allergy, Asthma and Clinical Immunology (EAACI

R. Naclerio, ;. Board, :. Gsk, . Merck, . Sanofi et al., AstraZeneca and Astellas; Yoshitaka Okamoto: Research grant from Torii Co, honoraria for lectures and advisory meetings from Kyorin

. Abbvie, . Sanofi, . Meda, . Gsk, . Novartis et al., Nikos Papadopoulos: grant from GSK, Nestl e, Merck -Fees from

A. Papi-;-chiesi-farmaceutici, B. Glaxosmithkline, M. Ingelheim, . Sharp-&amp;-dohme, . Menarini et al., Pfaar: has received research grants for his institution from ALK Abell o (Germany/Denmark), has received grants, personal fees, and non-financial support from AstraZeneca, p.7

M. P. Gmbh, Germany); and/or he has served as an advisor and on speakers' bureaus for some of the aforementioned companies. OP has received travel grants from HAL Allergy (the Netherlands/Germany) and Allergopharma (Germany), and he is a consultant for Bencard (Germany), HAL Allergy (the Netherlands), Guidepoint Global Advisors (USA), Thermo Fisher (Germany) and Stallergenes

A. Almirall, B. Astrazeneca, . Ingelheim, . Chiesi, . Meda et al., Dirkje Postma: The University of Groningen has received money for Professor Postma regarding an unrestricted educational grant for research from Astra Zeneca. Travel to ERS and/or ATS has been partially funded by Astra Zeneca, Chiesi, GSK, Takeda. Fees for consultancies were given to the University of Groningen by Astra Zeneca, Boehringer Ingelheim, Chiesi, GSK, Takeda and TEVA. Travel and lectures in China paid by Chiesi; David Price: Board Membership with Aerocrine, Davor Plavek: reports grants from Ministry of Science, Education and Sports of Republic of Croatia, grants and personal fees from GlaxoSmithKline, grants and personal fees from MSD, personal fees from Sandoz, personal fees from Salveo, grants from Schering-Plough, outside the submitted work

B. Aerocrine, . Ingelheim, . Mundipharma, N. Napp, and T. , Funding for patient enrolment or completion of research: Almirral, Chiesi, Teva, and Zentiva; and Peer reviewer for grant committees, Efficacy and Mechanism Evaluation programme, p.HTA, 2012.

D. Ryan, Board member URIACH and Stllargenes. received payments from GSK and MEDA to deliver lectures on their behalf. Chair of the Primary Care Interest Group of EAACI

M. Roman-rodriguez, GlaxoSmithKline, Novartis, Almirall, Chiesi, Mundipharma, Boehringer-Ingel

J. Bousquet and N. Khaltaev, Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases, vol.978, p.148, 2007.

M. Westman, C. Lupinek, J. Bousquet, N. Andersson, S. Pahr et al., Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence, J Allergy Clin Immunol, vol.135, pp.1199-1206, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02146839

J. Bousquet, J. M. Anto, K. Berkouk, P. Gergen, A. J. Pinto et al., Developmental determinants in non-communicable chronic diseases and ageing, Thorax, vol.70, pp.595-597, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01263281

J. Bousquet, J. E. Gern, F. D. Martinez, J. M. Anto, C. C. Johnson et al., Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop, J Allergy Clin Immunol, vol.133, pp.1535-1546, 2014.

T. Zuberbier, J. Lotvall, S. Simoens, S. V. Subramanian, and M. K. Church, Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review, Allergy, vol.69, pp.1275-1279, 2014.

J. Bousquet, C. P. Van, and N. Khaltaev, Allergic rhinitis and its impact on asthma, J Allergy Clin Immunol, vol.5, pp.147-334, 2001.
URL : https://hal.archives-ouvertes.fr/hal-02099400

J. Bousquet, N. Khaltaev, A. A. Cruz, J. Denburg, W. J. Fokkens et al., Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2) LEN and AllerGen), Allergy, vol.63, issue.86, pp.8-160, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00596392

S. Walker, S. Khan-wasti, M. Fletcher, P. Cullinan, J. Harris et al., Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study, J Allergy Clin Immunol, vol.120, pp.381-387, 2007.

B. Samolinski, A. Fronczak, A. Wlodarczyk, and J. Bousquet, Council of the European Union conclusions on chronic respiratory diseases in children, Lancet, vol.379, pp.45-46, 2012.

J. Bousquet, H. J. Schunemann, B. Samolinski, P. Demoly, C. E. Baena-cagnani et al., Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs, J Allergy Clin Immunol, vol.130, pp.1049-1062, 2012.

J. Bousquet, J. Michel, T. Standberg, G. Crooks, I. Iakovidis et al., The european innovation partnership on active and healthy ageing: the european geriatric medicine introduces the EIP on AHA column, Eur Geriatr Med, vol.5, pp.361-362, 2014.

J. Bousquet, J. Hajjam, F. Piette, B. Jean-bart, C. Wlosik et al., The French reference sites of the European Innovation Partnership on active and healthy ageing

, Presse Med, vol.42, pp.1558-1561, 2013.

J. Bousquet, A. Addis, I. Adcock, I. Agache, A. Agusti et al., Integrated care pathways for airway diseases (AIR-WAYS-ICPs), Eur Respir J, vol.44, pp.304-323, 2014.

W. J. Fokkens, V. J. Lund, J. Mullol, C. Bachert, I. Alobid et al., Rhinol Suppl, vol.23, p.3, 2012.

J. Bousquet, C. Bachert, G. W. Canonica, T. B. Casale, A. A. Cruz et al., Unmet needs in severe chronic upper airway disease (SCUAD), J Allergy Clin Immunol, vol.124, pp.428-433, 2009.

P. J. Bousquet, C. Bachert, G. W. Canonica, T. B. Casale, J. Mullol et al., Uncontrolled allergic rhinitis during treatment and its impact on quality of life: a cluster randomized trial, J Allergy Clin Immunol, vol.126, pp.666-668, 2010.

P. W. Hellings, W. J. Fokkens, C. Akdis, C. Bachert, C. Cingi et al., Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?, Allergy, vol.68, pp.1-7, 2013.

D. Marsh, C. Dechamp, P. Cour, J. Bousquet, and P. Deviller, Correlation between the atmospheric level of antigen Amb-al (AgE) and the number of Ambrosia artemisiaefolia pollen grains in Lyon and neighboring regions, Allerg Immunol (Paris), vol.1, p.43, 1987.

J. T. Buters, I. Weichenmeier, S. Ochs, G. Pusch, W. Kreyling et al., The allergen Bet v 1 in fractions of ambient air deviates from birch pollen counts, Allergy, vol.65, pp.850-858, 2010.

M. K. Agarwal, M. C. Swanson, C. E. Reed, and J. W. Yunginger, Airborne ragweed allergens: association with various particle sizes and short ragweed plant parts, J Allergy Clin Immunol, vol.74, pp.687-693, 1984.

D. A. Frenz, Interpreting atmospheric pollen counts for use in clinical allergy: spatial variability, Ann Allergy Asthma Immunol, vol.84, pp.481-489, 2000.

D. M. Caillaud, S. Martin, C. Segala, P. Vidal, J. Lecadet et al., Airborne pollen levels and drug consumption for seasonal allergic rhinoconjunctivitis: a 10-year study in France, Allergy, vol.70, pp.99-106, 2015.

C. Galan, C. Antunes, R. Brandao, C. Torres, H. Garcia-mozo et al., Airborne olive pollen counts are not representative of exposure to the major olive allergen Ole e 1, Allergy, vol.68, pp.809-812, 2013.

G. Frenguelli, G. Passalacqua, S. Bonini, A. Fiocchi, C. Incorvaia et al., Bridging allergologic and botanical knowledge in seasonal allergy: a role for phenology, Ann Allergy Asthma Immunol, vol.105, pp.223-227, 2010.

D. Caillaud, S. Martin, C. Segala, J. P. Besancenot, B. Clot et al., Ltd airborne birch pollen levels on clinical symptoms of seasonal allergic rhinoconjunctivitis, Int Arch Allergy Immunol, vol.70, pp.43-50, 2014.

D. M. Caillaud, S. Martin, C. Segala, J. P. Besancenot, B. Clot et al., Nonlinear short-term effects of airborne Poaceae levels on hay fever symptoms, J Allergy Clin Immunol, vol.130, pp.812-814, 2012.

I. Annesi-maesano, S. Rouve, H. Desqueyroux, R. Jankovski, J. M. Klossek et al., Grass pollen counts, air pollution levels and allergic rhinitis severity, Int Arch Allergy Immunol, vol.158, pp.397-404, 2012.

S. Lubitz, W. Schober, G. Pusch, R. Effner, N. Klopp et al., Polycyclic aromatic hydrocarbons from diesel emissions exert proallergic effects in birch pollen allergic individuals through enhanced mediator release from basophils, Environ Toxicol, vol.25, pp.188-197, 2010.

G. Boehm and R. M. Leuschner, Experiences with the 'Individual Pollen Collector' devel, Experientia Suppl, vol.51, pp.87-88, 1987.

M. K. Agarwal, M. C. Swanson, C. E. Reed, and J. W. Yunginger, Immunochemical quantitation of airborne short ragweed, Alternaria, antigen E, and Alt-I allergens: a two-year prospective study, J Allergy Clin Immunol, vol.72, pp.40-45, 1983.

S. Longhi, A. Cristofori, P. Gatto, F. Cristofolini, M. S. Grando et al., Biomolecular identification of allergenic pollen: a new perspective for aerobiological monitoring?, Ann Allergy Asthma Immunol, vol.103, pp.508-514, 2009.

E. Cassagne, P. D. Caillaud, J. P. Besancenot, and M. Thibaudon, Forecasting the onset of an allergic risk to poaceae in Nancy and Strasbourg (France) with different methods, Eur Ann Allergy Immunol, vol.39, pp.262-268, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00320604

N. Estrella, A. Menzel, U. Kramer, and H. Behrendt, Integration of flowering dates in phenology and pollen counts in aerobiology: analysis of their spatial and temporal coherence in Germany (1992-1999), Int J Biometeorl, vol.51, pp.49-59, 2006.

K. Laaidi, Predicting days of high allergenic risk during Betula pollination using weather types, Int J Biometeorl, vol.45, pp.124-132, 2001.

D. Myszkowska and R. Majewska, Pollen grains as allergenic environmental factors-new approach to the forecasting of the pollen concentration during the season, AAEM, vol.21, pp.681-688, 2014.

D. Voukantsis, U. Berger, F. Tzima, K. Karatzas, S. Jaeger et al., Personalized symptoms forecasting for pollen-induced allergic rhinitis sufferers

, Int J Biometeorl, vol.59, pp.889-897, 2015.

L. A. De-weger, T. Beerthuizen, P. S. Hiemstra, and J. K. Sont, Development and validation of a 5-day-ahead hay fever forecast for patients with grass-pollen-induced allergic rhinitis

, Int J Biometeorl, vol.58, pp.1047-1055, 2014.

S. V. Nuti, B. Wayda, I. Ranasinghe, S. Wang, R. P. Dreyer et al., The use of google trends in health care research: a systematic review, PLoS ONE, vol.9, p.109583, 2014.

D. A. Broniatowski, M. J. Paul, and M. Dredze, National and local influenza surveillance through Twitter: an analysis of the 2012-2013 influenza epidemic, PLoS ONE, vol.8, p.83672, 2013.

T. M. Bernardo, A. Rajic, I. Young, K. Robiadek, M. T. Pham et al., Scoping review on search queries and social media for disease surveillance: a chronology of innovation, J Med Internet Res, vol.15, p.147, 2013.

R. Mosges, A. M. El, H. E. Konig, and V. , What Google(R) knows about the pollen season, Allergy, vol.66, pp.707-708, 2011.

A. F. Dugas, M. Jalalpour, Y. Gel, S. Levin, F. Torcaso et al., Influenza forecasting with Google Flu Trends, PLoS ONE, vol.8, p.56176, 2013.

V. Konig and R. Mosges, A model for the determination of pollen count using google search queries for patients suffering from allergic rhinitis, J Allergy, p.381983, 2014.

U. Berger, M. Kmenta, and K. Bastl, Individual pollen exposure measurements: are they feasible?, Curr Opin Allergy Clinical Immunol, vol.14, pp.200-205, 2014.

M. Kmenta, K. Bastl, S. Jager, and U. Berger, Development of personal pollen information-the next generation of pollen information and a step forward for hay fever sufferers, Int J Biometeorl, vol.58, pp.1721-1726, 2014.

A. Lahdensuo, T. Haahtela, J. Herrala, T. Kava, K. Kiviranta et al., Randomised comparison of guided self management and traditional treatment of asthma over one year, BMJ, vol.312, pp.748-752, 1996.

A. Lahdensuo, T. Haahtela, J. Herrala, T. Kava, K. Kiviranta et al., Randomised comparison of cost effectiveness of guided self management and traditional treatment of asthma in Finland, BMJ, vol.316, pp.1138-1139, 1998.

T. Haahtela, L. E. Tuomisto, A. Pietinalho, T. Klaukka, M. Erhola et al., A 10 year asthma programme in Finland: major change for the better, Thorax, vol.61, pp.663-670, 2006.

L. C. Von-hertzen, J. Savolainen, M. Hannuksela, T. Klaukka, A. Lauerma et al., Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance, Allergy, vol.64, pp.678-701, 2009.

T. Haahtela, L. Von-hertzen, M. Makela, and M. Hannuksela, Finnish Allergy Programme 2008-2018-time to act and change the course, Allergy, vol.63, pp.634-645, 2008.

M. Deliu, D. Belgrave, A. Simpson, C. S. Murray, G. Kerry et al., Impact of rhinitis on asthma severity in school-age children, Allergy, vol.69, pp.1515-1521, 2014.

H. Campbell, R. Hotchkiss, N. Bradshaw, and M. Porteous, BMJ, vol.316, pp.133-137, 1998.

S. Overill, A practical guide to care pathways, J Integr Care, vol.2, pp.93-98, 1998.

, Integrated Care Pathways users in Scotland (ICPUS). A workbook for people starting to develop integrated care pathways

, How to produce and evaluate an integrated care pathway (ICP): information for staff. Great Ormond Street Hospital for Children. wwwgoshnhsuk, 2010.

S. Bruhn, Y. Fang, F. Barrenas, M. Gustafsson, H. Zhang et al., A generally applicable translational strategy identifies S100A4 as a candidate gene in allergy, Sci Translat Med, vol.6, pp.218-222, 2014.

C. Auffray, I. M. Adcock, K. F. Chung, R. Djukanovic, C. Pison et al., An integrative systems biology approach to understanding pulmonary diseases, Chest, vol.137, pp.1410-1416, 2010.

J. Bousquet, J. Anto, C. Auffray, M. Akdis, A. Cambon-thomsen et al., MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine, Allergy, vol.66, pp.596-604, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00595853

J. M. Anto, M. Pinart, M. Akdis, C. Auffray, C. Bachert et al., Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar, J Allergy Clin Immunol, vol.129, pp.943-954, 2012.

C. Lupinek, E. Wollmann, A. Baar, S. Banerjee, H. Breiteneder et al., Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip, Methods, vol.66, pp.106-119, 2014.

J. Bousquet, J. M. Anto, P. J. Sterk, I. M. Adcock, K. F. Chung et al., Systems medicine and integrated care to combat chronic noncommunicable diseases, Genome Med, vol.3, p.43, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01358549

I. Skrindo, C. Lupinek, R. Valenta, V. Hovland, S. Pahr et al., The use of the MeDALL-chip to assess IgE sensitization, a new diagnostic tool for allergic disease?, Pediatr Allergy Immunol, vol.26, pp.239-246, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02077053

I. Baiardini, P. J. Bousquet, Z. Brzoza, G. W. Canonica, E. Compalati et al., Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2) LEN taskforce position paper, Allergy, vol.70, pp.290-295, 2010.

O. Pfaar, P. Demoly, R. Gerth-van-wijk, S. Bonini, J. Bousquet et al., Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper, Allergy, vol.69, pp.854-867, 2014.

J. G. Ayres, B. Forsberg, I. Annesi-maesano, R. Dey, K. L. Ebi et al., Climate change and respiratory disease: European Respiratory Society position statement, Eur Respir J, vol.34, pp.295-302, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00595893

G. D&apos;amato, L. Cecchi, S. Bonini, C. Nunes, I. Annesi-maesano et al., Allergenic pollen and pollen allergy in Europe, Allergy, vol.62, pp.976-990, 2007.

T. Haahtela, Allergy is rare where butterflies flourish in a biodiverse environment, Allergy, vol.64, pp.1799-1803, 2009.

, ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma, Allergy, vol.59, pp.373-387, 2004.

J. L. Brozek, J. Bousquet, C. E. Baena-cagnani, S. Bonini, G. W. Canonica et al., Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision, J Allergy Clin Immunol, vol.126, pp.466-476, 2010.

A. Valero, M. Ferrer, E. Baro, J. Sastre, A. M. Navarro et al., Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis, Allergy, vol.65, pp.1609-1613, 2010.

J. Montoro, C. A. Del, J. Mullol, X. Molina, J. Bartra et al., Validation of the modified allergic rhinitis and its impact on asthma (ARIA) severity classification in allergic rhinitis children: the PEDRIAL study, Allergy, vol.67, pp.1437-1442, 2012.

J. Bousquet, J. M. Anto, P. Demoly, H. J. Schunemann, A. Togias et al., Severe chronic allergic (and related) diseases: a uniform approach-a MeDALL-GA2LEN-ARIA position paper, Int Arch Allergy Immunol, vol.158, pp.216-231, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00788048

, Expert panel report 3: Guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program. National Heart, Lung and Blood Institute. US Department of Health and Human Services. 440 pages, 2007.

J. Vestbo and S. Rennard, Chronic obstructive pulmonary disease biomarker(s) for disease activity needed-urgently, Am J Respir Crit Care Med, vol.182, pp.863-864, 2010.

S. Vijan, Type 2 diabetes, Ann Intern Med, vol.152, pp.31-46, 2010.

P. J. Bousquet, L. Bousquet-rouanet, C. Minh, H. B. Urbinelli, R. Allaert et al., Allergic Rhinitis and Its Impact on Asthma) classification of allergic rhinitis severity in clinical practice in France, Int Arch Allergy Immunol, vol.143, pp.163-169, 2007.

D. Lorenzo, G. Pacor, M. L. Amodio, E. Leto-barone, M. S. et al., Differences and similarities between allergic and nonallergic rhinitis in a large sample of adult patients with rhinitis symptoms, Int Arch Allergy Immunol, vol.155, pp.263-270, 2011.

D. Lu, Y. Zhao, Y. Zheng, A. P. Wang, L. Qiao et al., Evaluation of quality of life questionnaires for adult patients with moderate to severe allergic rhinitis, Am J Otolaryngol, vol.32, pp.494-498, 2011.

A. Del-cuvillo, J. Montoro, J. Bartra, A. Valero, M. Ferrer et al., Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients -The ADRIAL cohort study, Rhinology, vol.48, pp.201-205, 2010.

P. Demoly, R. Jankowski, O. Chassany, Y. Bessah, and F. A. Allaert, Validation of a selfquestionnaire for assessing the control of allergic rhinitis, Clin Exp Allergy, vol.41, pp.860-868, 2011.

K. Ohta, P. J. Bousquet, H. Aizawa, K. Akiyama, M. Adachi et al., Prevalence and impact of rhinitis in asthma. SACRA, a cross-sectional nation-wide study in Japan, Allergy, vol.66, pp.1287-1295, 2011.

S. M. Ragab, V. J. Lund, H. A. Saleh, and G. Scadding, Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy, Allergy, vol.61, pp.717-724, 2006.

A. Valero, M. Ferrer, J. Sastre, A. M. Navarro, L. Monclus et al., A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items, J Allergy Clin Immunol, vol.120, pp.359-365, 2007.

M. Schatz, E. O. Meltzer, R. Nathan, M. J. Derebery, M. Mintz et al., Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control, Ann Allergy Asthma Immunol, vol.104, pp.118-124, 2010.

P. Devillier, O. Chassany, E. Vicaut, O. De-beaumont, R. B. Dreyfus et al., The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass-pollen-induced allergic rhinoconjunctivitis, Allergy, vol.69, pp.1689-1695, 2014.

S. Grant, T. Aitchison, E. Henderson, J. Christie, S. Zare et al., A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise, Chest, vol.116, pp.1208-1217, 1999.

L. Pfennings, L. Cohen, and H. Van-der-ploeg, Preconditions for sensitivity in measuring change: visual analogue scales compared to rating scales in a Likert format, Psychol Rep, vol.77, pp.475-480, 1995.

P. J. Bousquet, C. Combescure, J. M. Klossek, J. P. Daures, and J. Bousquet, Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis, J Allergy Clin Immunol, vol.123, pp.1349-1354, 2009.

D. Ryan, C. Van-weel, J. Bousquet, E. Toskala, S. Ahlstedt et al., Primary care: the cornerstone of diagnosis of allergic rhinitis, Allergy, vol.63, pp.981-989, 2008.

M. Morais-almeida, N. Santos, A. M. Pereira, M. Branco-ferreira, C. Nunes et al., Prevalence and classification of rhinitis in preschool children in Portugal: a nationwide study, Allergy, vol.68, pp.1278-1288, 2013.

M. Morais-almeida, H. Pite, A. M. Pereira, A. Todo-bom, C. Nunes et al., Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal, Allergy, vol.68, pp.1150-1157, 2013.

J. Bousquet, C. Bachert, G. W. Canonica, J. Mullol, P. Van-cauwenberge et al., Efficacy of desloratadine in intermittent allergic rhinitis: a GALEN study, Allergy, vol.64, pp.1516-1523, 2009.

J. Bousquet, C. Bachert, G. W. Canonica, J. Mullol, P. Van-cauwenberge et al., Efficacy of desloratadine in persistent allergic rhinitis -a GA(2)LEN study, Int Arch Allergy Immunol, vol.153, pp.395-402, 2010.

D. Larenas-linnemann, H. Dinger, K. Shah-hosseini, A. Michels, and R. Mosges, Over diagnosis of persistent allergic rhinitis in perennial allergic rhinitis patients: a nationwide study in Mexico, Am J Rhinol Allergy, vol.27, pp.495-501, 2013.

J. Shao, Y. X. Cui, Y. F. Zheng, H. F. Peng, Z. L. Zheng et al., Efficacy and safety of sublingual immunotherapy in children aged 3-13 years with allergic rhinitis, Am J Rhinol Allergy, vol.28, pp.131-139, 2014.

H. Wei, Y. Zhang, L. Shi, J. Zhang, Y. Xia et al., Higher dosage of HIFU treatment may lead to higher and longer efficacy for moderate to severe perennial allergic rhinitis, Int J Med Sci, vol.10, pp.1914-1920, 2013.

E. C. Tatar, U. A. Surenoglu, G. Saylam, E. Isik, A. Ozdek et al., Is there any correlation between the results of skin-prick test and the severity of symptoms in allergic, Am J Rhinol Allergy, vol.70, pp.37-39, 2012.

S. Rouve, A. Didier, P. Demoly, R. Jankowsky, and J. M. Klossek, Anessi-Maesano I. Numeric score and visual analog scale in assessing seasonal allergic rhinitis severity, Rhinology, vol.48, pp.285-291, 2010.

I. Baiardini, F. Braido, S. Brandi, F. Tarantini, S. Bonini et al., The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review, Allergy, vol.63, pp.1015-1030, 2008.

P. J. Bousquet, P. Demoly, P. Devillier, K. Mesbah, and J. Bousquet, Impact of allergic rhinitis symptoms on quality of life in primary care, Int Arch Allergy Immunol, vol.160, pp.393-400, 2013.

H. Yamamoto, T. Yamada, M. Sakashita, S. Kubo, D. Susuki et al., Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis, Allergy Asthma Proc, vol.33, pp.17-22, 2012.

J. Bousquet, V. J. Lund, P. Van-cauwenberge, C. Bremard-oury, N. Mounedji et al., Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial, Allergy, vol.58, pp.733-741, 2003.

J. Bousquet, T. Bodez, P. Gehano, J. M. Klossek, F. Liard et al., Implementation of guidelines for allergic rhinitis in specialist practices. a randomized pragmatic controlled trial, Int Arch Allergy Immunol, vol.150, pp.75-82, 2009.

P. Demoly, P. J. Bousquet, K. Mesbah, J. Bousquet, and P. Devillier, Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis, Clin Exp Allergy, vol.43, pp.881-888, 2013.

G. Ciprandi, I. Cirillo, A. Pistorio, D. Gioacchino, M. Fenoglio et al., Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis, J Biol Regul Homeost Agents, vol.23, pp.31-36, 2009.

R. J. Davies, V. J. Lund, and H. Vj, The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis, Rhinology, vol.31, pp.159-164, 1993.

S. Henauer, L. Hugonot, R. Hugonot, A. Kurzeja, H. Gastpar et al., Multi-centre double-blind comparison of terfenadine once daily versus twice daily in patients with hay fever, J Int Med Res, vol.15, pp.212-223, 1987.

G. Newson-smith, M. Powell, M. Baehre, S. P. Garnham, and M. T. Macmahon, A placebo controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis

, Eur Arch Otorhinolaryngol, vol.254, pp.236-241, 1997.

B. Samolinski, A. Fronczak, P. Kuna, C. A. Akdis, J. M. Anto et al., Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union, Allergy, vol.67, pp.726-731, 2012.

B. Samolinski, A. J. Sybilski, F. Raciborski, A. Tomaszewska, P. Samel-kowalik et al., Prevalence of rhinitis in Polish population according to the ECAP (Epidemiology of Allergic Disorders in Poland) study, Otolaryngol Pol, vol.63, pp.324-330, 2009.

L. Klimek, C. Bachert, R. Mosges, U. Munzel, D. Price et al., Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study, Allergy Asthma Proc, vol.36, pp.40-47, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02142059

P. Azevedo, . Correia-dsj, J. Bousquet, A. Bugalho-almeida, G. S. Del et al., Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care, Prim Care Respir J, vol.22, pp.112-116, 2013.

J. A. Fonseca, L. Nogueira-silva, M. Morais-almeida, L. Azevedo, A. Sa-sousa et al., Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma, Allergy, vol.65, pp.1042-1048, 2010.

L. Nogueira-silva, S. V. Martins, R. Cruz-correia, L. F. Azevedo, M. Morais-almeida et al., Control of allergic rhinitis and asthma test-a formal approach to the development of a measuring tool, Respir Res, vol.10, p.52, 2009.

S. Van-der-leeuw, T. Van-der-molen, P. N. Dekhuijzen, J. A. Fonseca, F. A. Van-gemert et al., The minimal clinically important difference of the control of allergic rhinitis and asthma test (CARAT): cross-cultural validation and relation with pollen counts, NPJ Prim Care Respir Med, vol.25, p.14107, 2015.

O. Lourenco, S. Calado, A. Sa-sousa, and J. Fonseca, Evaluation of allergic rhinitis and asthma control in a Portuguese community pharmacy setting, J Managed care Special Pharm, vol.20, pp.513-522, 2014.

L. M. Borrego, J. A. Fonseca, A. M. Pereira, V. R. Pinto, D. Linhares et al., Development process and cognitive testing of CARATkids -Control of Allergic Rhinitis and Asthma Test for children, BMC Pediatr, vol.14, p.34, 2014.

D. V. Linhares, J. A. Da-fonseca, L. M. Borrego, A. Matos, A. M. Pereira et al., Validation of control of allergic rhinitis and asthma test for children (CARATKids)-a prospective multicenter study, Pediatr Allergy Immunol, vol.25, pp.173-179, 2014.

E. Burnay, R. Cruz-correia, J. T. Sousa, A. S. Fonseca, and J. , Challenges of a mobile application for asthma and allergic rhinitis patient enablement-interface and synchronization, Telemed J e-health, vol.19, pp.13-18, 2013.

F. Braido, I. Baiardini, E. Stagi, N. Scichilone, O. Rossi et al., Rhi-nAsthma patient perspective: a short daily asthma and rhinitis QoL assessment, Allergy, vol.67, pp.1443-1450, 2012.

T. J. Bright, A. Wong, R. Dhurjati, E. Bristow, L. Bastian et al., Effect of clinical decision-support systems: a systematic review, Ann Intern Med, vol.157, pp.29-43, 2012.

M. W. Jaspers, M. Smeulers, H. Vermeulen, and L. W. Peute, Effects of clinical decision-support systems on practitioner performance and patient outcomes: a synthesis of high-quality systematic review findings, J Am Med Inform Assoc, vol.18, pp.327-334, 2011.

R. Lavel, J. Bousquet, and C. Andre, Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebocontrolled trial of a standardized fivegrass-pollen extract in rhinitis, Allergy, vol.53, pp.493-498, 1998.

U. D. Reips and F. Funke, Interval-level measurement with visual analogue scales in Internet-based research: VAS Generator, Behav Res Methods, vol.40, pp.699-704, 2008.

G. F. Dunton, E. Dzubur, K. Kawabata, B. Yanez, B. Bo et al., Development of a smartphone application to measure physical activity using sensor-assisted self-report

, Front Publ Health, vol.2, p.12, 2014.

S. Shiffman, A. A. Stone, and M. R. Hufford, Ecological momentary assessment, Ann Rev Clin Psychol, vol.4, pp.1-32, 2008.

M. Radzuweit and U. Lechner, Introducing tablet computers into medical practice: design of mobile apps for consultation services, Health Technol Assess, vol.4, pp.31-41, 2014.

M. Lluch, Strategic Intelligence Monitor on Personal Health Systems phase, vol.2

, Evidence consolidation Report on best practices and key drivers of success, JRC-IPTS, 2012.

G. Dubey, Les nouvelles technologies en autonomie et sant e: un d eplacement des fronti eres de la connaissance Ann Mines, pp.82-88, 2014.

M. Beusart-z-ephir, P. Eklin, and S. Pelayo, Beuscart R. The human factors engineering approach to biomedical informatics projects: state of the art, results, benefits and challenges, Yearb Med Inform, pp.109-136, 2007.

K. Wang, C. Wang, L. Xi, Y. Zhang, Y. Ouyang et al., Ltd trial to assess adherence to allergic rhinitis treatment following a daily short message service (SMS) via the mobile phone, A randomized controlled Allergy, vol.70, pp.51-58, 2014.

T. De-jongh, I. Gurol-urganci, V. Vodopivec-jamsek, J. Car, and R. Atun, Mobile phone messaging for facilitating self-management of long-term illnesses, Cochrane Database Syst Rev, vol.12, p.7459, 2012.

I. Gurol-urganci, T. De-jongh, V. Vodopivec-jamsek, R. Atun, and J. Car, Mobile phone messaging reminders for attendance at healthcare appointments, Cochrane Database Syst Rev, vol.12, p.7458, 2013.

G. W. Canonica, L. Cox, R. Pawankar, C. E. Baena-cagnani, M. Blaiss et al., Sublingual immunotherapy: World Allergy Organization position paper 2013 update, World Allergy Organ J, vol.7, p.6, 2014.

, Council conclusions on Healthy Ageing across the Lifecycle. 3206th Employment, social policy, ehalth and consumer affairs Council meeting, 2012.

J. Bousquet, C. C. Tanasescu, T. Camuzat, J. M. Anto, F. Blasi et al., Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliamen, Allergy, vol.68, pp.555-561, 2013.

A. J. Frew, L. Dubuske, P. K. Keith, C. J. Corrigan, W. Aberer et al., Assessment of specific immunotherapy efficacy using a novel placebo score-based method

, Ann Allergy Asthma Immunol, vol.109, pp.342-347, 2012.

J. Bousquet, E. Mantzouranis, A. A. Cruz, N. Ait-khaled, C. E. Baena-cagnani et al., Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma, J Allergy Clin Immunol, vol.126, pp.926-938, 2010.

P. J. Beggs and H. J. Bambrick, Is the global rise of asthma an early impact of anthropogenic climate change?, Environ Health Perspect, vol.113, pp.915-919, 2005.

P. D. Hollins, P. S. Kettlewell, M. D. Atkinson, D. B. Stephenson, J. M. Corden et al., Relationships between airborne fungal spore concentration of Cladosporium and the summer climate at two sites in Britain, Int J Biometeorl, vol.48, pp.137-141, 2004.

A. J. Deak, L. Makra, I. Matyasovszky, Z. Csepe, and B. Muladi, Climate sensitivity of allergenic taxa in Central Europe associated with new climate change related forces, Sci Total Environ, vol.442, pp.36-47, 2012.

W. L. De and P. S. Hiemstra, The effect of climate change on pollen allergy in the Netherlands, Ned Tijdschr Geneeskd, vol.153, p.1410, 2009.

J. Emberlin, M. Detandt, R. Gehrig, S. Jaeger, N. Nolard et al., Responses in the start of Betula (birch) pollen seasons to recent changes in spring temperatures across Europe, Int J Biometeorl, vol.46, pp.159-170, 2002.

A. H. Fitter and R. S. Fitter, Rapid changes in flowering time in British plants, Science, vol.296, pp.1689-1691, 2002.

A. Stach, J. Emberlin, M. Smith, B. Adams-groom, and D. Myszkowska, Factors that determine the severity of Betula spp. pollen seasons in Poland (Poznan and Krakow) and the United Kingdom (Worcester and London), Int J Biometeorl, vol.52, pp.311-321, 2008.

M. Smith, J. Emberlin, A. Stach, M. Czarnecka-operacz, D. Jenerowicz et al., Regional importance of Alnus pollen as an aeroallergen: a comparative study of Alnus pollen counts from Worcester (UK) and Poznan (Poland), AAEM, vol.14, pp.123-128, 2007.

H. Garcia-mozo, C. Galan, V. Jato, J. Belmonte, . De-lgc et al., Quercus pollen season dynamics in the Iberian peninsula: response to meteorological parameters and possible consequences of climate change, AAEM, vol.13, pp.209-224, 2006.

J. Emberlin, J. Mullins, J. Corden, S. Jones, W. Millington et al., Regional variations in grass pollen seasons in the UK, long-term trends and forecast models, Clin Exp Allergy, vol.29, pp.347-356, 1999.

P. Wayne, S. Foster, J. Connolly, F. Bazzaz, and P. Epstein, Production of allergenic pollen by ragweed (Ambrosia artemisiifolia L.) is increased in CO2-enriched atmospheres

, Ann Allergy Asthma Immunol, vol.88, pp.279-282, 2002.

L. H. Ziska, D. E. Gebhard, D. A. Frenz, S. Faulkner, B. D. Singer et al., Cities as harbingers of climate change: common ragweed, urbanization, and public health, J Allergy Clin Immunol, vol.111, pp.290-295, 2003.

T. Frei and E. Gassner, Climate change and its impact on birch pollen quantities and the start of the pollen season an example from Switzerland for the period 1969-2006, Int J Biometeorl, vol.52, pp.667-674, 2008.

J. U. Ahlholm, M. L. Helander, and J. Savolainen, Genetic and environmental factors affecting the allergenicity of birch

, Clin Exp Allergy, vol.28, pp.1384-1388, 1998.

N. A. Molfino, A. S. Slutsky, and N. Zamel, The effects of air pollution on allergic bronchial responsiveness, Clin Exp Allergy, vol.22, pp.667-672, 1992.

H. Behrendt, W. M. Becker, C. Fritzsche, W. Sliwa-tomczok, J. Tomczok et al., Air pollution and allergy: experimental studies on modulation of allergen release from pollen by air pollutants, Int Arch Allergy Immunol, vol.3, pp.69-74, 1997.

G. D&apos;amato, Environmental urban factors (air pollution and allergens) and the rising trends in allergic respiratory diseases, Allergy, vol.57, pp.30-33, 2002.

K. M. Shea, R. T. Truckner, R. W. Weber, and D. B. Peden, Climate change and allergic disease, J Allergy Clin Immunol, vol.122, pp.443-453, 2008.

E. De-manuel-keenoy, M. David, J. Mora, L. Prieto, C. Domingo et al., Activation of Stratification Strategies and Results of the interventions on frail patients of Healthcare Services (ASSEHS) DG Sanco Project No, Eur Geriatr Med, vol.12, pp.342-346, 2013.

, Allergy, vol.70, pp.1372-1392, 2015.